Helden Esmee van, Kranendonk Josephine, Vermulst Ad, Boer Arjen de, Reuver Philip de, Rosman Camiel, Wilt Johannes de, Laarhoven Kees van, Scheffer Gert Jan, Keijzer Christiaan, Warlé Michiel
Radboudumc, Nijmegen, Gelderland, The Netherlands
Radboudumc, Nijmegen, Gelderland, The Netherlands.
Reg Anesth Pain Med. 2025 Aug 5;50(8):651-657. doi: 10.1136/rapm-2024-105277.
Increasing evidence supports a positive relationship between the intensity of early postoperative pain, and the risk of 30-day postoperative complications. Higher pain levels may hamper recovery and contribute to immunosuppression after surgery. This leaves patients at risk of postoperative complications.
One thousand patients who underwent major abdominal surgery (cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, esophageal, liver, or pancreas surgery) at the Radboud university medical center were randomly selected from eligible patients between 2014 and 2020. Pain scores on day 1, the independent variable of interest, were extracted from the electronic patient files. Outcome measures were 30-day postoperative complications (infectious, non-infectious, total complications and classification according to Clavien-Dindo).
Seven hundred ninety complications occurred in 572 patients within 30 days after surgery, of which 289 (36.7%) were of infectious origin, and 501 (63.4%) complications were non-infectious. The mean duration from the end of surgery to the occurrence of infectious complications was 6.5 days (SD 5.6) and 4.1 days (SD 4.7) for non-infectious complications (p<0.001). Logistic regression analysis revealed that pain scores on postoperative day 1 (POD1) were significantly positively associated with 30-day total complications after surgery (OR=1.132, 95% CI (1.076 to 1.190)), Clavien-Dindo classification (OR=1.131, 95% CI (1.071 to 1.193)), infectious complications (OR=1.126, 95% CI (1.059 to 1.196)), and non-infectious complications (OR=1.079, 95% CI (1.022 to 1.140)).
After major abdominal surgery, higher postoperative pain scores on day 1 are associated with an increased risk of 30-day postoperative complications. Further studies should pursue whether optimization of perioperative analgesia can improve immune homeostasis, reduce complications after surgery and enhance postoperative recovery.
越来越多的证据支持术后早期疼痛强度与术后30天并发症风险之间存在正相关关系。较高的疼痛水平可能会阻碍恢复,并导致术后免疫抑制。这使患者面临术后并发症的风险。
从2014年至2020年符合条件的患者中,随机选取1000例在拉德堡德大学医学中心接受大腹部手术(细胞减灭术和热灌注化疗、食管、肝脏或胰腺手术)的患者。从电子病历中提取感兴趣的自变量,即术后第1天的疼痛评分。观察指标为术后30天并发症(感染性、非感染性、总并发症以及根据Clavien-Dindo分类)。
572例患者在术后30天内发生了790例并发症,其中289例(36.7%)为感染性并发症,501例(63.4%)并发症为非感染性。感染性并发症从手术结束到发生的平均持续时间为6.5天(标准差5.6),非感染性并发症为4.1天(标准差4.7)(p<0.001)。逻辑回归分析显示,术后第1天(POD1)的疼痛评分与术后30天总并发症(OR=1.132,95%置信区间(1.076至1.190))、Clavien-Dindo分类(OR=1.131,95%置信区间(1.071至1.193))、感染性并发症(OR=1.126,95%置信区间(1.059至1.196))和非感染性并发症(OR=1.079,95%置信区间(1.022至1.140))显著正相关。
大腹部手术后,术后第1天较高的疼痛评分与术后30天并发症风险增加相关。进一步的研究应探讨围手术期镇痛的优化是否能改善免疫稳态、减少术后并发症并促进术后恢复。